DelveInsight’s, “Advanced Gastric Carcinoma Pipeline Insight, 2024,” report provides comprehensive insights about 50+...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - MOUNTAINTODAY.IN - A La Une - 21/Jun 19:12
Advanced Non-Squamous & Squamous NSCLC Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight
DelveInsight’s, “Advanced Non-Squamous & Squamous NSCLC Pipeline Insight, 2024,” report provides comprehensive insights about 9+ companies and 11+ pipeline drugs in Advanced Non-Squamous & Squamous NSCLC pipeline landscape. It covers the Advanced Non-Squamous &
Articles similaires
Major Depressive Disorder Pipeline 2024 | GH Research, Praxis Precision Medicines, AbbVie, Gedeon Richter, Intra-Cellular Therapies, Bristol-Myers Squibb, Relmada Therapeutics, SAGE Therapeutics,
mountaintoday.in - 09/Jul 18:48
DelveInsight, “Major Depressive Disorder Pipeline Insight 2024” report provides comprehensive insights about 75+ companies and 75+...
Advanced Hepatocellular Carcinoma Pipeline 2024 | CStone Pharmaceuticals, TaiRx, Yiviva, AVEO Oncology, Eureka Therapeutics, Shanghai Henlius Biotech, Innovent Biologics, Akesobio, BeiGene
mountaintoday.in - 04/Jul 17:44
DelveInsight’s, “Advanced Hepatocellular Carcinoma Pipeline Insight 2024” report provides comprehensive insights...
Advanced Merkel Cell Carcinoma Pipeline 2024 | Xencor, Inc., Incyte Corporation, Millennium Pharmaceuticals, Inc., Exelixis, Bristol-Myers Squibb, bluebird bio, Affini-T Therapeutics
mountaintoday.in - 04/Jul 18:08
DelveInsight’s, “Advanced Merkel cell carcinoma Pipeline Insight 2024” report provides comprehensive insights...
Hypertension Pipeline 2024 | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Ionis Pharmaceuticals, Future Medicine, Pharmosa BioPharm, Aerovate Therapeutics, Novartis,
mountaintoday.in - 11/Jul 18:48
DelveInsight, “Hypertension Pipeline Insight 2024” report provides comprehensive insights about 100+ Hypertension companies and 100+...
Osteoarthritis Pipeline 2024 | Biosplice Therapeutics, Gilead Sciences, Flexion Therapeutics, GlaxoSmithKline, Levicept, Arthrogen, Personalized Stem Cells, Peptinov, Asahi Kasei Pharma
mountaintoday.in - 11/Jul 18:28
DelveInsight’s, “Osteoarthritis Pipeline Insight 2024” report provides comprehensive insights about 130+ companies...
Basal Cell Carcinoma Pipeline 2024 | PellePharm, MedC Biopharma Corporation, AiViva BioPharma, MediWound, Kintara Therapeutics, IO Biotech, Sirnaomics, Aresus Pharma
mountaintoday.in - 04/Jul 17:48
DelveInsight’s, “Basal Cell Carcinoma Pipeline Insight 2024” report provides comprehensive insights about 25+...
Gastrointestinal Stromal Tumors Pipeline 2024 | Jiangsu Hengrui Medicine, Daiichi Sankyo Company, Cogent Biosciences, Advenchen Laboratories, Chia Tai Tianqing Pharmaceutical Group, AB Science
mountaintoday.in - 11/Jul 15:04
DelveInsight’s, “Gastrointestinal Stromal Tumors Pipeline Insight 2024” report provides comprehensive insights...
Neuroendocrine Tumors Pipeline 2024 | Amgen, Eli Lilly and Company, GlaxoSmithKline, Hutchison Medipharma Limited, Ipsen, Seneca Therapeutics, Crinetics Pharmaceuticals, ADC Therapeutics, BeiGene
mountaintoday.in - 11/Jul 15:12
DelveInsight’s, “Neuroendocrine Tumors Pipeline Insight 2024” report provides comprehensive insights about 115+...
Leiomyosarcoma Pipeline 2024 | Merck, Advenchen Laboratories, Trillium Therapeutics, PTC Therapeutics, PharmaMar, Philogen, EMD Serono, Incyte Corporation, Clovis Oncology Inc.
mountaintoday.in - 11/Jul 15:28
DelveInsight’s, “Leiomyosarcoma Pipeline Insight 2024” report provides comprehensive insights about 10+ companies and...
Les derniers communiqués
-
Aucun élément